HLA-DPB1-COL11A2 and Three Additional Xmhc Loci Are Independently Associated with RA in a UK Cohort

Total Page:16

File Type:pdf, Size:1020Kb

HLA-DPB1-COL11A2 and Three Additional Xmhc Loci Are Independently Associated with RA in a UK Cohort Genes and Immunity (2011) 12, 169–175 & 2011 Macmillan Publishers Limited All rights reserved 1466-4879/11 www.nature.com/gene ORIGINAL ARTICLE HLA-DPB1-COL11A2 and three additional xMHC loci are independently associated with RA in a UK cohort G Orozco1, A Barton1, S Eyre1, B Ding2, J Worthington1,XKe1,3,4 and W Thomson1,4 1Arthritis Research UK Epidemiology Unit, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; 2Karolinska Institute, Stockholm, Sweden and 3Institute of Child Health, University College London, London, UK The aim of this study was to investigate the complex association pattern of the extended major histocompatibility complex (xMHC) region with rheumatoid arthritis (RA) susceptibility to identify effects independent of HLA-DRB1. A total of 1804 RA cases and 1474 controls were included. High-resolution HLA-DRB1 typing was performed. Subjects were genotyped for 1546 single-nucleotide polymorphisms (SNPs) using Affymetrix GeneChip 500 K (Santa Clara, CA, USA) as part of the Wellcome Trust Case Control Consortium Study. Statistical analysis was carried out using PLINK. To avoid confounding by RA- associated HLA-DRB1 alleles, we analyzed xMHC SNPs using a data set with pairwise matching of cases and controls on DRB1 genotypes. A total of 594 case–control pairs with identical DRB1 genotypes were identified. After this adjustment, 104 SNPs remained significantly associated with RA (Po0.05), suggesting that additional RA loci independent of HLA-DRB1 can be found in the xMHC region. Of these, four loci showed the strongest associations with RA (Po0.005): ZNF391, the olfactory receptor (OR) gene cluster, C6orf26-RDBP and HLA-DPB1-COL11A2. An additional locus mapping to the BTN (butyrophilin) cluster showed independent association with RA in anti-cyclic citrullinated peptide-positive patients exclusively. We have validated the previously described independent association of the HLA-DPB1-COL11A2 locus with RA. In addition, association with three novel independent RA loci in the xMHC region (ZNF391, OR2H1 and C6orf26-RDBP) has been detected. Genes and Immunity (2011) 12, 169–175; doi:10.1038/gene.2010.57; published online 3 February 2011 Keywords: rheumatoid arthritis; xMHC; susceptibility; HLA-DRB1 Introduction methods revealed that the association of the HLA-DRB1 locus with RA is complex, with a variety of specific Rheumatoid arthritis (RA) is a common disease, affecting alleles conferring different risks. These alleles share a around 1% of the population worldwide. It is an sequence in the third hypervariable region of the gene inflammatory, autoimmune, systemic disease and is char- termed the shared epitope.5 Since then, countless studies acterized by the chronic inflammation and progressive have demonstrated that HLA-DRB1 is consistently linked destruction of the joints that leads to disability.1 RA is a and associated with RA in every population studied.6 complex disease, meaning that multiple genetic variants, HLA-DRB1 lies within the major histocompatibility environmental factors and random events interact to trigger complex (MHC) on chromosome 6p21. The classical pathological pathways. Although many of these etiological extended MHC (MHCx) encompasses a region of factors have not yet been identified, recent groundbreaking B3.6 Mb and it is divided into three subregions (classes advances such as the availability of genome-wide associa- I, II and III), whereas the xMHC encompasses a B7.8 Mb. tion studies have expanded our knowledge about the It is characterized by its great variability and gene genetic factors that contribute to RA, such that 26 loci have density. Many of these genes have immunological now been confirmed (Po5 Â 10À8).2 functions, and variation within the MHC has been found However, the HLA-DRB1 locus identified long before to be associated with the majority of autoimmune the advent of genome-wide association studies remains diseases.7 The region is also characterized by the the major RA susceptibility locus. The association of presence of strong linkage disequilibrium (LD). HLA-DRB1 alleles with RA was described for the first A variety of approaches have been used to determine time in the 1970s.3,4 Subsequent molecular typing whether additional RA susceptibility loci reside within the MHC region, but interpretation of these associations is made difficult by the strong LD and insufficient Correspondence: Dr G Orozco, Arthritis Research UK Epidemiology coverage of the region in many of the studies.8–13 More Unit, Manchester Academic Health Science Centre, University of recently, dense single-nucleotide polymorphism (SNP)- Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, mapping studies have identified several loci conferring UK. RA susceptibility independently of HLA-DRB1 risk E-mail: [email protected] 4These authors share senior authorship. alleles using novel statistical approaches to avoid Received 26 April 2010; revised and accepted 25 June 2010; confounding.14–16 Validation in independent data sets is published online 3 February 2011 particularly important to confirm new RA loci in the Association of xMHC with RA G Orozco et al 170 MHC. The Wellcome Trust Case Control Consortium HLA-G-HLA-A locus, whereas the other four showed (WTCCC) Study provides an ideal data source for this stronger evidence of individual independent effects purpose.17 In the present study, this large and well- (Supplementary Figure 2). Therefore, we have found at characterized data set was examined for the identifica- least four xMHC loci associated with RA independently tion and validation of HLA-DRB1-independent RA of HLA-DRB1: risk loci. Locus 1: close to ZNF391 in the extended class I region; Locus 2: close to OR2H1 in the extended class I region; Locus 3:closetoC6orf26-RDBP in the class III region; and Results Locus 4: HLA-DPB1-COL11A2 in the class II region. In the initial unmatched analysis, we found 745 It has been shown that HLA alleles are differentially SNPs significantly associated with RA (P trendo0.05; associated with anti-cyclic citrullinated peptide (CCP)- Figure 1a). Of these, 192 markers reached genome- positive and -negative disease. Therefore, we next wide significance (Po5 Â 10À7, as defined in the analyzed the unmatched data in anti-CCP-positive and original WTCCC Study17) and 269 were significant anti-CCP-negative patients separately. The anti-CCP þ after Bonferroni correction of the xMHC region (Po3.2 Â subgroup showed a similar pattern of association 10À5). Many of the strongest associations were observed compared with the whole data set, with the strongest in the vicinity of the HLA-DRB1 locus, although a associations around the HLA-DRB1 locus and evidence number of suggestive additional signals closer to the of additional signals (Figure 1b). On the contrary, only telomere were detected. the HLA-DRB1 region surpassed the GW significance To avoid confounding by RA-associated HLA-DRB1 threshold in the anti-CCPÀ subgroup (Figure 1c). alleles, we performed HLA-DRB1 case–control matching Next, we carried out HLA-DRB1-matched analysis at a ratio 1:1, as previously described.14 Given the stratified according to the presence or absence of anti- stringent selection strategy, we expected a decrease in CCP antibodies. A total of 296 and 119 matched case– the statistical power, as the number of individuals control pairs were available for the anti-CCP þ and anti- included in the analysis was reduced significantly (594 CCPÀ groups, respectively. Three loci were associated case–control pairs). A significance threshold was set at with anti-CCP þ RA, independently of HLA-DRB1,at Po0.005, and five loci were identified to be associated Po0.005: the butyrophilin (BTN)-gene cluster locus with RA independently of HLA-DRB1, that is, ZNF391, (particularly in the BTN2A2-BTN3A1 region), HLA-B- OR2H1-OR2H2, HLA-G-HLA-A, C6orf26-RDBP and HCP5 and HLA-DPB1-COL11A2 (Table 2 and Figure 2b). HLA-DPB1-COL11A2 (Table 1 and Figure 2a). Conditional logistic regression analysis provided sup- To further test whether these five loci represent effects port that they represented true independent effects independent of each other and the rest of the region, we (Supplementary Figure 3). In addition, the olfactory performed conditional logistic regression analysis for the receptor (OR) locus could also represent another strongest associated SNP within each locus, conditioning independent effect (P ¼ 0.007) (Figure 2b). With regard on all the SNPs analyzed across the xMHC region. to the anti-CCP-patient subgroup, ZNF391, the OR This analysis also allows the visual display of the in- cluster, and HLA-DPB1-COL11A2 showed some evi- dependence of a locus (a dip and/or a spike against dence of association with RA (P ¼ 0.01), but the weaker the xMHC), as shown in Supplementary Figure 2. A association was primarily due to the smaller sample very complex association pattern was found for the size, in comparison with the anti-CCP þ subgroup 80 80 70 70 60 60 50 50 40 40 -logP -logP 30 30 20 20 10 10 0 0 25700 26700 27700 28700 29700 30700 31700 32700 2570026700 27700 28700 29700 30700 31700 32700 Position on Chr6 (Kb) Position on Chr6 (Kb) 8 7 6 5 4 -logP 3 2 1 0 2570026700 27700 28700 29700 30700 31700 32700 Position on Chr6 (Kb) Figure 1 Unmatched association analysis of 1546 SNPs in the xMHC region using the whole RA cohort (1804 RA patients and 1474controls) (a), anti-CCP þ (1042 RA patients and 1804 controls) (b) and anti-CCPÀ (270 RA patients and 1804 controls) (c) patients
Recommended publications
  • Transcriptomic Signatures of Brain Regional Vulnerability to Parkinsonâ
    ARTICLE https://doi.org/10.1038/s42003-020-0804-9 OPEN Transcriptomic signatures of brain regional vulnerability to Parkinson’s disease Arlin Keo 1,2, Ahmed Mahfouz 1,2, Angela M.T. Ingrassia3, Jean-Pascal Meneboo4,5, Celine Villenet4, Eugénie Mutez6,7,8, Thomas Comptdaer 6,7, Boudewijn P.F. Lelieveldt2,9, Martin Figeac4,5, ✉ ✉ ✉ Marie-Christine Chartier-Harlin 6,7 , Wilma D.J. van de Berg 3 , Jacobus J. van Hilten 10 & 1234567890():,; ✉ Marcel J.T. Reinders 1,2 The molecular mechanisms underlying caudal-to-rostral progression of Lewy body pathology in Parkinson’s disease remain poorly understood. Here, we identified transcriptomic sig- natures across brain regions involved in Braak Lewy body stages in non-neurological adults from the Allen Human Brain Atlas. Among the genes that are indicative of regional vulner- ability, we found known genetic risk factors for Parkinson’s disease: SCARB2, ELOVL7, SH3GL2, SNCA, BAP1, and ZNF184. Results were confirmed in two datasets of non- neurological subjects, while in two datasets of Parkinson’s disease patients we found altered expression patterns. Co-expression analysis across vulnerable regions identified a module enriched for genes associated with dopamine synthesis and microglia, and another module related to the immune system, blood-oxygen transport, and endothelial cells. Both were highly expressed in regions involved in the preclinical stages of the disease. Finally, altera- tions in genes underlying these region-specific functions may contribute to the selective regional vulnerability in Parkinson’s disease brains. 1 Leiden Computational Biology Center, Leiden University Medical Center, Leiden, The Netherlands. 2 Delft Bioinformatics Lab, Delft University of Technology, Delft, The Netherlands.
    [Show full text]
  • 3020.Full-Text.Pdf
    Published OnlineFirst March 30, 2015; DOI: 10.1158/1078-0432.CCR-14-2804 Biology of Human Tumors Clinical Cancer Research DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic Markers Aguirre A. de Cubas1, Esther Korpershoek2, Lucia Inglada-Perez 1,3, Eric Letouze4, Maria Curras-Freixes 1, Agustin F. Fernandez 5,Inaki~ Comino-Mendez 1, Francesca Schiavi6, Veronika Mancikova1, Graeme Eisenhofer7,8, Massimo Mannelli9, Guiseppe Opocher6,10, Henri Timmers11, Felix Beuschlein12, Ronald de Krijger13, Alberto Cascon1,3, Cristina Rodríguez-Antona1,3, Mario F. Fraga5,14, Judith Favier15,16, Anne-Paule Gimenez-Roqueplo15,16,17,18, and Mercedes Robledo1,3 Abstract Purpose: Pheochromocytoma and paraganglioma (PPGL) are these, 48 CpGs showed significant associations with time to rare neuroendocrine tumors, associated with highly variable progression even after correcting for SDHB genotype, suggesting postoperative evolution. The scarcity of reliable PPGL prognostic their value as prognostic markers independent of genetic back- markers continues to complicate patient management. In this ground. Hypermethylation of RDBP (negative elongation study, we explored genome-wide DNA methylation patterns in factor complex member E) in metastatic tumors was further the context of PPGL malignancy to identify novel prognostic validated by bisulfite pyrosequencing [Dbmetastatic-benign ¼ 0.29, markers. P ¼ 0.003; HR, 1.4; 95% confidence interval (CI), 1.1–2.0; P ¼ Experimental Design: We retrospectively investigated DNA 0.018] and may alter transcriptional networks involving (RERG, methylation patterns in PPGL with and without metastases using GPX3, and PDZK1) apoptosis, invasion, and maintenance of high-throughput DNA methylation profiling data (Illumina 27K) DNA integrity. from two large, well-characterized discovery (n ¼ 123; 24 met- Conclusions: This is the first large-scale study of DNA methy- astatic) and primary validation (n ¼ 154; 24 metastatic) series.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights Into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle
    animals Article Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle Masoumeh Naserkheil 1 , Abolfazl Bahrami 1 , Deukhwan Lee 2,* and Hossein Mehrban 3 1 Department of Animal Science, University College of Agriculture and Natural Resources, University of Tehran, Karaj 77871-31587, Iran; [email protected] (M.N.); [email protected] (A.B.) 2 Department of Animal Life and Environment Sciences, Hankyong National University, Jungang-ro 327, Anseong-si, Gyeonggi-do 17579, Korea 3 Department of Animal Science, Shahrekord University, Shahrekord 88186-34141, Iran; [email protected] * Correspondence: [email protected]; Tel.: +82-31-670-5091 Received: 25 August 2020; Accepted: 6 October 2020; Published: 9 October 2020 Simple Summary: Hanwoo is an indigenous cattle breed in Korea and popular for meat production owing to its rapid growth and high-quality meat. Its yearling weight and carcass traits (backfat thickness, carcass weight, eye muscle area, and marbling score) are economically important for the selection of young and proven bulls. In recent decades, the advent of high throughput genotyping technologies has made it possible to perform genome-wide association studies (GWAS) for the detection of genomic regions associated with traits of economic interest in different species. In this study, we conducted a weighted single-step genome-wide association study which combines all genotypes, phenotypes and pedigree data in one step (ssGBLUP). It allows for the use of all SNPs simultaneously along with all phenotypes from genotyped and ungenotyped animals. Our results revealed 33 relevant genomic regions related to the traits of interest.
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • Association of Gene Ontology Categories with Decay Rate for Hepg2 Experiments These Tables Show Details for All Gene Ontology Categories
    Supplementary Table 1: Association of Gene Ontology Categories with Decay Rate for HepG2 Experiments These tables show details for all Gene Ontology categories. Inferences for manual classification scheme shown at the bottom. Those categories used in Figure 1A are highlighted in bold. Standard Deviations are shown in parentheses. P-values less than 1E-20 are indicated with a "0". Rate r (hour^-1) Half-life < 2hr. Decay % GO Number Category Name Probe Sets Group Non-Group Distribution p-value In-Group Non-Group Representation p-value GO:0006350 transcription 1523 0.221 (0.009) 0.127 (0.002) FASTER 0 13.1 (0.4) 4.5 (0.1) OVER 0 GO:0006351 transcription, DNA-dependent 1498 0.220 (0.009) 0.127 (0.002) FASTER 0 13.0 (0.4) 4.5 (0.1) OVER 0 GO:0006355 regulation of transcription, DNA-dependent 1163 0.230 (0.011) 0.128 (0.002) FASTER 5.00E-21 14.2 (0.5) 4.6 (0.1) OVER 0 GO:0006366 transcription from Pol II promoter 845 0.225 (0.012) 0.130 (0.002) FASTER 1.88E-14 13.0 (0.5) 4.8 (0.1) OVER 0 GO:0006139 nucleobase, nucleoside, nucleotide and nucleic acid metabolism3004 0.173 (0.006) 0.127 (0.002) FASTER 1.28E-12 8.4 (0.2) 4.5 (0.1) OVER 0 GO:0006357 regulation of transcription from Pol II promoter 487 0.231 (0.016) 0.132 (0.002) FASTER 6.05E-10 13.5 (0.6) 4.9 (0.1) OVER 0 GO:0008283 cell proliferation 625 0.189 (0.014) 0.132 (0.002) FASTER 1.95E-05 10.1 (0.6) 5.0 (0.1) OVER 1.50E-20 GO:0006513 monoubiquitination 36 0.305 (0.049) 0.134 (0.002) FASTER 2.69E-04 25.4 (4.4) 5.1 (0.1) OVER 2.04E-06 GO:0007050 cell cycle arrest 57 0.311 (0.054) 0.133 (0.002)
    [Show full text]
  • The Function and Evolution of C2H2 Zinc Finger Proteins and Transposons
    The function and evolution of C2H2 zinc finger proteins and transposons by Laura Francesca Campitelli A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Molecular Genetics University of Toronto © Copyright by Laura Francesca Campitelli 2020 The function and evolution of C2H2 zinc finger proteins and transposons Laura Francesca Campitelli Doctor of Philosophy Department of Molecular Genetics University of Toronto 2020 Abstract Transcription factors (TFs) confer specificity to transcriptional regulation by binding specific DNA sequences and ultimately affecting the ability of RNA polymerase to transcribe a locus. The C2H2 zinc finger proteins (C2H2 ZFPs) are a TF class with the unique ability to diversify their DNA-binding specificities in a short evolutionary time. C2H2 ZFPs comprise the largest class of TFs in Mammalian genomes, including nearly half of all Human TFs (747/1,639). Positive selection on the DNA-binding specificities of C2H2 ZFPs is explained by an evolutionary arms race with endogenous retroelements (EREs; copy-and-paste transposable elements), where the C2H2 ZFPs containing a KRAB repressor domain (KZFPs; 344/747 Human C2H2 ZFPs) are thought to diversify to bind new EREs and repress deleterious transposition events. However, evidence of the gain and loss of KZFP binding sites on the ERE sequence is sparse due to poor resolution of ERE sequence evolution, despite the recent publication of binding preferences for 242/344 Human KZFPs. The goal of my doctoral work has been to characterize the Human C2H2 ZFPs, with specific interest in their evolutionary history, functional diversity, and coevolution with LINE EREs.
    [Show full text]
  • (P -Value<0.05, Fold Change≥1.4), 4 Vs. 0 Gy Irradiation
    Table S1: Significant differentially expressed genes (P -Value<0.05, Fold Change≥1.4), 4 vs. 0 Gy irradiation Genbank Fold Change P -Value Gene Symbol Description Accession Q9F8M7_CARHY (Q9F8M7) DTDP-glucose 4,6-dehydratase (Fragment), partial (9%) 6.70 0.017399678 THC2699065 [THC2719287] 5.53 0.003379195 BC013657 BC013657 Homo sapiens cDNA clone IMAGE:4152983, partial cds. [BC013657] 5.10 0.024641735 THC2750781 Ciliary dynein heavy chain 5 (Axonemal beta dynein heavy chain 5) (HL1). 4.07 0.04353262 DNAH5 [Source:Uniprot/SWISSPROT;Acc:Q8TE73] [ENST00000382416] 3.81 0.002855909 NM_145263 SPATA18 Homo sapiens spermatogenesis associated 18 homolog (rat) (SPATA18), mRNA [NM_145263] AA418814 zw01a02.s1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:767978 3', 3.69 0.03203913 AA418814 AA418814 mRNA sequence [AA418814] AL356953 leucine-rich repeat-containing G protein-coupled receptor 6 {Homo sapiens} (exp=0; 3.63 0.0277936 THC2705989 wgp=1; cg=0), partial (4%) [THC2752981] AA484677 ne64a07.s1 NCI_CGAP_Alv1 Homo sapiens cDNA clone IMAGE:909012, mRNA 3.63 0.027098073 AA484677 AA484677 sequence [AA484677] oe06h09.s1 NCI_CGAP_Ov2 Homo sapiens cDNA clone IMAGE:1385153, mRNA sequence 3.48 0.04468495 AA837799 AA837799 [AA837799] Homo sapiens hypothetical protein LOC340109, mRNA (cDNA clone IMAGE:5578073), partial 3.27 0.031178378 BC039509 LOC643401 cds. [BC039509] Homo sapiens Fas (TNF receptor superfamily, member 6) (FAS), transcript variant 1, mRNA 3.24 0.022156298 NM_000043 FAS [NM_000043] 3.20 0.021043295 A_32_P125056 BF803942 CM2-CI0135-021100-477-g08 CI0135 Homo sapiens cDNA, mRNA sequence 3.04 0.043389246 BF803942 BF803942 [BF803942] 3.03 0.002430239 NM_015920 RPS27L Homo sapiens ribosomal protein S27-like (RPS27L), mRNA [NM_015920] Homo sapiens tumor necrosis factor receptor superfamily, member 10c, decoy without an 2.98 0.021202829 NM_003841 TNFRSF10C intracellular domain (TNFRSF10C), mRNA [NM_003841] 2.97 0.03243901 AB002384 C6orf32 Homo sapiens mRNA for KIAA0386 gene, partial cds.
    [Show full text]
  • Deep Sequencing of the Human Retinae Reveals the Expression of Odorant Receptors
    fncel-11-00003 January 20, 2017 Time: 14:24 # 1 CORE Metadata, citation and similar papers at core.ac.uk Provided by Frontiers - Publisher Connector ORIGINAL RESEARCH published: 24 January 2017 doi: 10.3389/fncel.2017.00003 Deep Sequencing of the Human Retinae Reveals the Expression of Odorant Receptors Nikolina Jovancevic1*, Kirsten A. Wunderlich2, Claudia Haering1, Caroline Flegel1, Désirée Maßberg1, Markus Weinrich1, Lea Weber1, Lars Tebbe2, Anselm Kampik3, Günter Gisselmann1, Uwe Wolfrum2, Hanns Hatt1† and Lian Gelis1† 1 Department of Cell Physiology, Ruhr-University Bochum, Bochum, Germany, 2 Department of Cell and Matrix Biology, Johannes Gutenberg University of Mainz, Mainz, Germany, 3 Department of Ophthalmology, Ludwig Maximilian University of Munich, Munich, Germany Several studies have demonstrated that the expression of odorant receptors (ORs) occurs in various tissues. These findings have served as a basis for functional studies that demonstrate the potential of ORs as drug targets for a clinical application. To the best of our knowledge, this report describes the first evaluation of the mRNA expression of ORs and the localization of OR proteins in the human retina that set a Edited by: stage for subsequent functional analyses. RNA-Sequencing datasets of three individual Hansen Wang, University of Toronto, Canada neural retinae were generated using Next-generation sequencing and were compared Reviewed by: to previously published but reanalyzed datasets of the peripheral and the macular Ewald Grosse-Wilde, human retina and to reference tissues. The protein localization of several ORs was Max Planck Institute for Chemical Ecology (MPG), Germany investigated by immunohistochemistry. The transcriptome analyses detected an average Takaaki Sato, of 14 OR transcripts in the neural retina, of which OR6B3 is one of the most highly National Institute of Advanced expressed ORs.
    [Show full text]
  • Functional and Structural Characterization of Olfactory Receptors in Human Heart and Eye
    DISSERTATION to obtain the degree Doctor Rerum Naturalium (Dr.rer.nat.) at the Faculty of Biology and Biotechnology International Graduate School Biosciences Ruhr-University Bochum Functional and structural characterization of olfactory receptors in human heart and eye Department of Cellphysiology submitted by Nikolina Jovancevic from Zadar, Croatia Bochum February 2016 First Referee: Prof. Dr. Dr. Dr. Hanns Hatt Second Referee: Prof. Dr. Stefan Wiese DISSERTATION zur Erlangung des Grades eines Doktors der Naturwissenschaften der Fakultät für Biologie und Biotechnologie an der Internationalen Graduiertenschule Biowissenschaften der Ruhr-Universität Bochum Funktionale und strukturelle Charakterisierung olfaktorischer Rezeptoren im humanen Herzen und Auge Lehrstuhl für Zellphysiologie vorgelegt von Nikolina Jovancevic aus Zadar, Kroatien Bochum Februar 2016 Referent: Prof. Dr. Dr. Dr. Hanns Hatt Korreferent: Prof. Dr. Stefan Wiese To my family TABLE OF CONTENTS TABEL OF CONTENT 1 INTRODUCTION 1 1.1 G protein-coupled receptors 1 1.1.1 General 1 1.1.2 Structure and classification 2 1.1.3 Olfactory Receptors 4 1.2 Function of olfactory receptors 9 1.2.1 The olfactory system 9 1.2.2 Ectopic expression of olfactory receptors 11 1.3 Excursus: Anatomy and physiology of the heart 13 1.3.1 Anatomy of the heart and blood circuit 14 1.3.2 The cardiac conduction system 15 1.3.3 Excitation-contraction coupling 16 1.3.4 Cardiac GPCRs: Modulation of cardiac contraction 17 1.4 Excursus: Anatomy and physiology of the eye 18 1.4.1 Anatomy of the retina 19
    [Show full text]
  • Arp40431 P050
    Aviva Systems Biology RDBP antibody - N-terminal region (ARP40431_P050) Product Number ARP40431_P050 Product Page http://www.avivasysbio.com/rdbp-antibody-n-terminal-region-arp40431-p050.html Product Name RDBP antibody - N-terminal region (ARP40431_P050) Size 100 ul Gene Symbol NELFE Alias Symbols D6S45, NELF-E, RD, RDP, RDBP Protein Size (# AA) 380 amino acids Molecular Weight 43kDa Product Format Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. NCBI Gene Id 7936 Host Rabbit Clonality Polyclonal Concentration Batch dependent within range: 100 ul at 0.5 - 1 mg/ml Official Gene Full RD RNA binding protein Name Description This is a rabbit polyclonal antibody against RDBP. It was validated on Western Blot using a cell lysate as a positive control. Aviva Systems Biology strives to provide antibodies covering each member of a whole protein family of your interest. We also use our best efforts to provide you antibodies recognize various epitopes of a target protein. For availability of antibody needed for your experiment, please inquire ([email protected]). Peptide Sequence Synthetic peptide located within the following region: LVIPPGLSEEEEALQKKFNKLKKKKKALLALKKQSSSSTTSQGGVKRSLS Target Reference Rao,J.N., (2008) Biochemistry 47 (12), 3756-3761 Description of RDBP is part of a complex termed negative elongation factor (NELF) which represses Target RNA polymerase II transcript elongation. This protein bears similarity to nuclear RNA- binding proteins; however, it has not been demonstrated that this protein binds RNA. The protein contains a tract of alternating basic and acidic residues, largely arginine (R) and aspartic acid (D).The protein encoded by this gene is part of a complex termed negative elongation factor (NELF) which represses RNA polymerase II transcript elongation.
    [Show full text]
  • COBRA1 Monoclonal Antibody, Clone F7E4
    COBRA1 monoclonal antibody, Gene Symbol: COBRA1 clone F7E4 Gene Alias: DKFZp586B0519, KIAA1182, NELF-B, NELFB Catalog Number: MAB8174 Gene Summary: NELFB is a subunit of negative Regulatory Status: For research use only (RUO) elongation factor (NELF), which also includes NELFA (WHSC2; MIM 606026), either NELFC or NELFD (TH1L; Product Description: Mouse monoclonal antibody MIM 605297), and NELFE (RDBP; MIM 154040). NELF raised against full length recombinant COBRA1. acts with DRB sensitivity-inducing factor (DSIF), a Clone Name: F7E4 heterodimer of SPT4 (SUPT4H1; MIM 603555) and SPT5 (SUPT5H; MIM 602102), to cause transcriptional Immunogen: Recombinant protein corresponding to full pausing of RNA polymerase II (see MIM 180660) (Narita length human COBRA1. et al., 2003 [PubMed 12612062]).[supplied by OMIM] Host: Mouse References: 1. COBRA1 inhibits AP-1 transcriptional activity in Theoretical MW (kDa): 62 transfected cells. Zhong H, Zhu J, Zhang H, Ding L, Sun Y, Huang C, Ye Q. Biochem Biophys Res Commun. Reactivity: Human,Mouse,Rat 2004 Dec 10;325(2):568-73. 2. Attenuation of estrogen receptor alpha-mediated Applications: WB-Ti transcription through estrogen-stimulated recruitment of (See our web site product page for detailed applications a negative elongation factor. Aiyar SE, Sun JL, Blair AL, information) Moskaluk CA, Lu YZ, Ye QN, Yamaguchi Y, Mukherjee A, Ren DM, Handa H, Li R. Genes Dev. 2004 Sep Protocols: See our web site at 1;18(17):2134-46. http://www.abnova.com/support/protocols.asp or product page for detailed protocols Specificity: This antibody has been directly tested for reactivity in Western blots with human, mouse and rat tissue.
    [Show full text]